Valuation: Cosmos Health Inc.

Market Cap 2.79Cr 2.5Cr 2.31Cr 2.09Cr 3.9Cr 265.93Cr 3.97Cr 28Cr 11Cr 139.18Cr 10Cr 10Cr 440.8Cr P/E 2026 *
-1.85x
P/E 2027 * 3.96x
Enterprise Value 2.79Cr 2.5Cr 2.31Cr 2.09Cr 3.9Cr 265.93Cr 3.97Cr 28Cr 11Cr 139.18Cr 10Cr 10Cr 440.8Cr EV / Sales 2026 *
0.33x
EV / Sales 2027 * 0.22x
Free-Float
74.12%
Yield 2026 *
-
Yield 2027 * -
1 day+11.45%
1 week+9.68%
Current month-35.45%
1 month-34.05%
3 months+51.89%
6 months-22.42%
Current year-44.28%
1 week 0.22
Extreme 0.2182
0.28
1 month 0.22
Extreme 0.2182
0.42
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
0.95
3 years 0.16
Extreme 0.1616
1.65
5 years 0.16
Extreme 0.1616
113.75
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 26/02/2016
Director of Finance/CFO 43 11/11/2020
Chief Operating Officer 56 01/02/2023
Director TitleAgeSince
Director/Board Member 58 13/01/2014
Chairman 60 26/02/2016
Director/Board Member 59 18/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Buy

Chief Executive Officer

3,49,825 0.5635%
29/07/26 Free

Chief Financial Officer

3,28,407 0.5290%
29/07/26 Buy

Chief Executive Officer

7,66,284 1.2344%
Change 5-day change 1-year change 3-year change Capi.($)
+11.45%+9.68%-70.04%-72.25% 2.51Cr
+6.63%+5.13%+68.86%+145.20% 1,14800Cr
+1.53%+2.84%+47.48%+89.01% 65TCr
+1.68%+1.96%+29.16%+109.31% 51TCr
+0.73%+2.45%+54.26%+68.96% 38TCr
+3.83%-0.62%+69.01%+42.32% 35TCr
+2.38%+2.65%+34.31%+57.95% 29TCr
+2.26%+0.55%+3.92%+28.92% 26TCr
+1.97%+3.01%+57.91%+76.14% 24TCr
+4.03%+5.36%+39.76%+116.14% 20TCr
Average +3.25%+3.15%+33.46%+66.17% 40.37TCr
Weighted average by Cap. +2.25%+2.89%+50.22%+95.97%

Financials

2026 *2027 *
Net sales 8.54Cr 7.65Cr 7.06Cr 6.39Cr 12Cr 813.32Cr 12Cr 84Cr 34Cr 425.66Cr 32Cr 31Cr 1.35TCr 13Cr 12Cr 11Cr 9.69Cr 18Cr 1.23TCr 18Cr 127.77Cr 51Cr 645.9Cr 49Cr 48Cr 2.05TCr
Net income 59.66L 53.44L 49.3L 44.61L 83.42L 57Cr 84.77L 5.88Cr 2.35Cr 30Cr 2.24Cr 2.19Cr 94Cr 88.12L 78.93L 72.82L 65.89L 1.23Cr 84Cr 1.25Cr 8.69Cr 3.47Cr 44Cr 3.31Cr 3.24Cr 139.1Cr
Net Debt - -
Projected Income Statement - Annual - Cosmos Health Inc.
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
29/26/29 $0.2775 +11.45% 18,47,264
28/26/28 $0.2490 +5.51% 26,31,620
27/26/27 $0.2360 +1.55% 22,99,933
26/26/26 $0.2324 -10.96% 33,09,286
23/26/23 $0.2610 +3.16% 26,77,959
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Cosmos Health Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2775USD
Average target price
2.950USD
Spread / Average Target
+963.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cosmos Health Inc.
  1. Stock Market
  2. Stocks
  3. COSM Stock